immunotherapy in the management of metastatic triple negative breast cancer
Published 3 years ago • 221 plays • Length 6:11Download video MP4
Download video MP3
Similar videos
-
4:41
optimizing immunotherapy for the treatment of metastatic, triple negative breast cancer
-
7:40
study of carboplatin plus nivolumab in metastatic triple-negative breast cancer
-
38:56
navigating the management of triple-negative breast cancer: immunotherapy considerations
-
1:49
the role of immunotherapy in triple negative breast cancer
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
13:38
near complete remission in stage 4 triple negative breast cancer | #integrativeoncology | aohc
-
52:09
immunotherapy for breast cancer
-
43:41
revolutionising triple negative breast cancer treatment
-
1:35
longer overall survival in metastatic tnbc with pembrolizumab - medpage today
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
4:22
immunotherapy in early triple-negative breast cancer: new data and future directions
-
2:21
how immunotherapy might be effective for triple-negative breast cancer
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
55:01
advances in treatment of triple-negative breast cancer: a success story
-
21:36
treatment planning for triple negative breast cancer | 2022 evolution conference
-
0:51
challenges in the treatment of mtnbc
-
6:16
latest on immunotherapy in triple-negative breast cancer - medpage today
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
5:04
immunotherapy and triple negative breast cancer - mayo clinic
-
32:04
educational sessions: "management of special subtypes of tnbc"
-
4:26
updates in the neoadjuvant management of triple negative breast cancer
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer